Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/OCF ratio is N/A as of 2026-10-06T12:50:27.331Z.
Calculation as of: 2026-10-06T12:50:27.331Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f9f7ef7d03019e78f4201474ef0c74f9c2a497de6c29d743f28e52983e243880
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2024-08-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
N/A
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Amylyx Pharmaceuticals, Inc.
Market Cap
$3.09B
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.15B
Price/OCF Ratio
80.03
TTM Avg
106.08
3Y Avg
106.08
5Y Avg
106.08
Market Cap
$3.16B
Price/OCF Ratio
N/A
TTM Avg
16.06
3Y Avg
20.39
5Y Avg
20.39
Market Cap
$2.87B
Price/OCF Ratio
19.65
TTM Avg
24.35
3Y Avg
65.42
5Y Avg
65.42
Market Cap
$3.44B
Price/OCF Ratio
17.72
TTM Avg
27.05
3Y Avg
38.50
5Y Avg
38.50
Market Cap
$2.69B
Price/OCF Ratio
16.01
TTM Avg
17.24
3Y Avg
48.15
5Y Avg
48.31
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | $3.09B | N/A | N/A | N/A | N/A |
| Arcutis Biotherapeutics, Inc. (ARQT)vs › | $3.15B | 80.03 | 106.08 | 106.08 | 106.08 |
| Denali Therapeutics Inc. (DNLI)vs › | $3.16B | N/A | 16.06 | 20.39 | 20.39 |
| Enliven Therapeutics, Inc. (ELVN)vs › | $3.25B | N/A | N/A | N/A | N/A |
| Dyne Therapeutics, Inc. (DYN)vs › | $2.88B | N/A | N/A | N/A | N/A |
| TransMedics Group, Inc. (TMDX)vs › | $2.87B | 19.65 | 24.35 | 65.42 | 65.42 |
| AtriCure, Inc. (ATRC)vs › | $2.87B | 44.15 | 33.50 | 475.62 | 475.62 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.44B | 17.72 | 27.05 | 38.50 | 38.50 |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.69B | 16.01 | 17.24 | 48.15 | 48.31 |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 12.77 | 10.38 | 21.92 | 19.88 |
P/OCF Ratio
N/A
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2024-08-08 | 7.40 |
| 2024-08-07 | 7.73 |
| 2024-08-06 | 8.10 |
| 2024-08-05 | 8.10 |
| 2024-08-02 | 8.31 |
| 2024-08-01 | 8.51 |
| 2024-07-31 | 8.47 |
| 2024-07-30 | 7.85 |
| 2024-07-29 | 7.98 |
| 2024-07-26 | 8.10 |
| 2024-07-25 | 7.89 |
| 2024-07-24 | 7.89 |
| 2024-07-23 | 8.06 |
| 2024-07-22 | 8.14 |
| 2024-07-19 | 8.31 |
| 2024-07-18 | 8.22 |
| 2024-07-17 | 8.72 |
| 2024-07-16 | 9.70 |
| 2024-07-15 | 8.88 |
| 2024-07-12 | 8.88 |
| 2024-07-11 | 9.38 |
| 2024-07-10 | 8.51 |
| 2024-07-09 | 6.78 |
| 2024-07-08 | 6.78 |
| 2024-07-05 | 7.07 |
| 2024-07-03 | 7.28 |
| 2024-07-02 | 7.15 |
| 2024-07-01 | 7.73 |
| 2024-06-28 | 7.81 |
| 2024-06-27 | 7.94 |
| 2024-06-26 | 7.52 |
| 2024-06-25 | 7.61 |
| 2024-06-24 | 7.52 |
| 2024-06-21 | 7.32 |
| 2024-06-20 | 6.78 |
| 2024-06-18 | 6.66 |
| 2024-06-17 | 6.78 |
| 2024-06-14 | 6.74 |
| 2024-06-13 | 6.91 |
| 2024-06-12 | 7.03 |
| 2024-06-11 | 7.15 |
| 2024-06-10 | 7.24 |
| 2024-06-07 | 7.28 |
| 2024-06-06 | 7.24 |
| 2024-06-05 | 7.24 |
| 2024-06-04 | 7.03 |
| 2024-06-03 | 6.99 |
| 2024-05-31 | 7.07 |
| 2024-05-30 | 6.91 |
| 2024-05-29 | 6.87 |
| 2024-05-28 | 7.03 |
| 2024-05-24 | 7.11 |
| 2024-05-23 | 7.32 |
| 2024-05-22 | 7.52 |
| 2024-05-21 | 7.40 |
| 2024-05-20 | 7.57 |
| 2024-05-17 | 7.52 |
| 2024-05-16 | 7.52 |
| 2024-05-15 | 7.48 |
| 2024-05-14 | 7.69 |
| 2024-05-13 | 7.48 |
| 2024-05-10 | 7.24 |
| 2024-05-09 | 10.97 |
| 2024-05-08 | 11.20 |
| 2024-05-07 | 11.44 |
| 2024-05-06 | 11.55 |
| 2024-05-03 | 11.79 |
| 2024-05-02 | 11.61 |
| 2024-05-01 | 11.20 |
| 2024-04-30 | 10.51 |
| 2024-04-29 | 11.03 |
| 2024-04-26 | 10.22 |
| 2024-04-25 | 10.33 |
| 2024-04-24 | 10.91 |
| 2024-04-23 | 11.32 |
| 2024-04-22 | 11.50 |
| 2024-04-19 | 10.86 |
| 2024-04-18 | 11.50 |
| 2024-04-17 | 11.61 |
| 2024-04-16 | 11.67 |
| 2024-04-15 | 12.02 |
| 2024-04-12 | 12.19 |
| 2024-04-11 | 13.29 |
| 2024-04-10 | 14.28 |
| 2024-04-09 | 15.50 |
| 2024-04-08 | 15.62 |
| 2024-04-05 | 15.21 |
| 2024-04-04 | 15.15 |
| 2024-04-03 | 15.27 |
| 2024-04-02 | 15.21 |
| 2024-04-01 | 15.73 |
| 2024-03-28 | 16.49 |
| 2024-03-27 | 16.72 |
| 2024-03-26 | 15.91 |
| 2024-03-25 | 15.73 |
| 2024-03-22 | 15.91 |
| 2024-03-21 | 16.66 |
| 2024-03-20 | 17.24 |
| 2024-03-19 | 17.01 |
| 2024-03-18 | 16.60 |
| 2024-03-15 | 18.81 |
| 2024-03-14 | 18.40 |
| 2024-03-13 | 19.97 |
| 2024-03-12 | 19.97 |
| 2024-03-11 | 22.06 |
| 2024-03-08 | 19.51 |
| 2024-03-07 | 110.13 |
| 2024-03-06 | 110.60 |
| 2024-03-05 | 109.43 |
| 2024-03-04 | 111.12 |
| 2024-03-01 | 108.62 |
| 2024-02-29 | 109.43 |
| 2024-02-28 | 113.61 |
| 2024-02-27 | 110.31 |
| 2024-02-26 | 101.95 |
| 2024-02-23 | 102.47 |
